RNAi Technology Market

Global RNAi Technology Market Size (2024 to 2032)

The size of the global RNAi technology market is expected to grow to USD 8.48 billion by 2032 from USD 2.81 billion in 2024, registering a CAGR of 14.8% from 2024 to 2032.

Current Scenario of the Global RNAi Technology Market

RNAi technology is becoming so popular in today’s world because of its potential in treating various chronic diseases like cancer and other genetical disorders. It is not only used in treating various diseases but is also most effective in crop improvement and pest control. RNAi technology is the most familiar way to treat various types of cancer cells in the human body. It is proven that the most advanced stage of cancer tumor can also be suppressed using RNAi technology, which emerged with the latest technological developments in healthcare. The growing prominence for personalized medicines where the development of the drug according to the specific requirements of the patients to cure the targeted diseases can also be succeeded using the RNAi technology.

MARKET DRIVERS

Y-o-Y growth in the cancer patient population propels the global RNAi technology market growth.

The demand to launch new or innovative drugs that are highly effective in treating chronic diseases like cancer is inclined to adopt prominent features of RNAi technology, which shall fuel the market’s growth rate. According to American Cancer Society Journals, around 1,958,310 cancer cases were registered in 2023 only in the United States. The frequency of cancer patients is projected to grow at a higher pace in the coming years as well. The burden of cancer disease is becoming a huge concern in the United States. It is estimated that 2,001,140 new cases will be registered in the U.S. by the end of 2024, and 611,720 people are expected to die from the cancer disease in 2024. Cancer is a curable disease if diagnosed and treated properly at the right times. The government initiative programs to create awareness among people to promote the importance of early diagnosis steps for cancer disease greatly increase the growth rate of the RNAi technology market. People in urban cities are more likely to be affected by cancer due to sedentary lifestyles. The increasing popularity of the available diagnosis and treatment procedures in urban cities is solely to fuel the growth rate of the RNAi technology market.

RNAi technology has major benefits in providing protection for crops against pests, diseases, and pathogens. Research and development activities in agriculture are embedded in launching a new scope to protect the crop and increase the total production rate. RNAi technology has significant potential to enhance the overall crop production rate by manipulating the genes involved in biomass, which further enhances the shelf life of the plants. This factor is attributed to amplifying the growth rate of the RNAi technology market. The growing focus on improving the food production rate to fulfill the requirements of the incredibly growing population across the world is slightly to level up the growth rate of the market.

In recent R&D activities, RNAi technology is proven to show highly positive results in fighting against HIV and Cancer diseases. There is a high scope for RNAi technology in the coming years due to its therapeutic modality to cure such diseases, which is showcasing a positive response to the growth rate of the market in the coming years. In the latest discovery in the healthcare sector, RNAi technology can be most popularly used as an alternative to traditional antiviral therapy. The viral infection can be treated through RNAi technology via direct silencing of viral genes, which can be an effective way to treat different viral infections. On the other hand, RNAi technology is also highly beneficial for patients suffering from hepatitis. According to the World Health Organization (WHO), more than 6000 people are diagnosed with hepatitis each day across the world. On April 19, 2024, WHO issued an alert on viral hepatitis with an alarming number of deaths annually in 2022 and 2023. The adoption of significant treatment procedures in healthcare, like using RNAi technology, can limit the number of deaths due to hepatitis as it can reduce the risk factors and eventually leverage the market’s growth rate during the forecast period.

MARKET RESTRAINTS

The lack of complete knowledge in RNAi technology, as research activities are still underway in the healthcare sector, hinders the global market growth.

There are many research activities going on using RNAi technology, where acquiring the complete knowledge to implement in specific applications is a bit difficult. Also, high investments in R&D activities are to limit the market’s growth rate. Research and development activities need high investments, and the results are unpredictable. Government authorities show less privilege in investing, especially in undeveloped countries, which may eventually impede the growth rate of the market. Though RNAi technology has higher benefits, factors like altering genetic crop composition can quietly reduce the growth rate of the RNAi technology market in some cases. Inappropriate use of the RNAi technology may lead to ambiguous results, which may decline the opportunities for market growth during the forecast period.  The gene target through RNAi technology takes a very long time, and the clinical testing procedures are also involved in promoting valid therapeutics in the healthcare sector, which prominently hampering the overall market’s growth rate during this period.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global RNAi Technology Market Analysis By Application

The therapeutics segment is leading with the largest share of the market, whereas the drug discovery and development segment is expected to have a prominent growth rate during the forecast period. The rising prevalence of cancer patients across the world is subjected to promote the growth rate of the therapeutics segment. The changes in lifestyles and an increasing number of infectious diseases due to unhealthy food habits are inclined to promote the need for an innovative drug that further elevates the growth rate of the drug discovery and development segment. Government initiative steps to reduce the impact of novel infectious diseases by investing huge amounts in drug discoveries through various innovative methods at a higher pace account for prompting the market’s growth rate.

Global RNAi Technology Market Analysis By End User

Pharmaceutical & Biotechnology companies’ segment is leading with the highest share of the market. RNAi technology's effectiveness in treating various chronic illnesses is exclusively to promote opportunities in pharmaceutical and biotechnology companies. The concern about the prominent treatment procedure for cancer is increasing from time to time, and the quick adoption of RNAi technology may showcase positive results in treating cancer cells through gene therapy. The academic and research institutes segment is likely to grow at a faster rate during the forecast period. Ongoing R&D activities include launching innovative drugs or the best treatment procedures for various chronic illnesses.

REGIONAL ANALYSIS

North America had the largest share of the global RNAi technology market in 2023.

High per capita income and the presence of topmost companies in the healthcare sector are attributed to escalating the growth rate of the market in North America. Regulating infectious diseases using gene therapy is becoming increasingly important in countries like the U.S. and Canada. The research and clinical laboratories in the U.S. are mainly focused on introducing various therapeutic procedures for chronic and infectious diseases, which is escalating the growth rate of the market. The presence of the most advanced technologies in the U.S. is booming to adopt the powerful therapeutic strategy, which is ascribed to elevating the market’s growth rate.

The Asia Pacific region is likely to hit the highest CAGR.

The demand to avail the most advanced treatment procedures with the growing number of elderly populations in major countries like India and China is likely to fuel the market’s growth rate. It is expected that the number of elderly populations may reach 347 million by 2050. Elderly people are more prone to infectious diseases, and the deal to launch innovative drugs or other treatment procedures using RNAi technology will lead to an effective result in the healthcare sector, which will potentially impel the market’s growth rate in India.

Europe is expected to grow steadily during the forecast period in the worldwide market.

Europe is next to North America in leading the prominent share of the RNAi technology market. Government bodies support citizens through subsidies through various healthcare insurance policies, which are ascribed to bolstering the market’s growth rate in Europe.

KEY PARTICIPANTS IN THE GLOBAL RNAi TECHNOLOGY MARKET

Alnylam Pharmaceuticals, OriGene Technologies, Inc., Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Silence Therapeutics, Ionis Pharmaceuticals, Merck & Co., Qiagen N.V., Thermo Fisher Scientific, Synlogic, Benitec Biopharma, Gradalis, Sirnaomics, Inc., Marina Biotech, Quark Pharmaceuticals, Regulus Therapeutics, GeneCare Research Institute Co., Ltd., ASC Therapeutics are some of the key market players in RNAi technology market.

RECENT HAPPENINGS IN THE GLOBAL MARKET

• In 2023, Alnylam Pharmaceuticals received a favorable recommendation from the FDA advisory committee panel for the expansion of Alnylam’s RNAi drug development to treat cardiomyopathy. The Phase III Apollo-B trial was closely reviewed by the committee, and the drug showed positive results on functional capacity and quality of life.
• In 2023, Arrowhead Pharmaceuticals announced its plan to open a Good Manufacturing Plant (GMP) plant and laboratories in Verona, United States. The new facility heads towards the development of the targeted RNA interference platform and leads RNAi-based drug candidates with the most advanced technologies.

DETAILED SEGMENTATION OF THE GLOBAL RNAI TECHNOLOGY MARKET INCLUDED IN THIS REPORT

This research report on the global RNAi technology market has been segmented and sub-segmented based on the following categories.

By Application

• Drug Discovery and Development
• Therapeutics
  • Neurology
  • Oncology
  • Infectious Diseases
  • Metabolic Diseases
  • Others
• Functional Genomics
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CROs & CMOs
• Others

By Region

• North America
• Europe
• Asia Pacific 
• Latin America
• Middle East and Africa